CDX2, COX2 and MUC2 expressions in rarrett's esophagus: Can they be useful in determination of the dysplasia?
![Thumbnail](/xmlui/themes/Mirage2//images/restricted.png)
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2012Yazar
Türkmen, İlknur ÇetinaslanBaşsüllü, Nuray
Uraz, Süleyman
Yerdel, Mehmet Ali
Memişoğlu, Reşat
Bülbül Doğusoy, Gülen
Üst veri
Tüm öğe kaydını gösterKünye
Türkmen IÇ, Başsüllü N, Uraz S, Yerdel MA, Memışoğlu R, Bülbül Doğusoy G. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?. Türk Patoloji Dergisi. 2012; 28(3): 251-8. doi: 10.5146/tjpath.2012.01132.Özet
Objective: The description of Barrett's esophagus which is a risk factor for esophageal adenocarcinoma has differences, and the need of goblet cells for diagnosis is controversial. However, the pathophysiology in the metaplasia seen in Barrett's esophagus is not totally understood and new methods are searched for the assessment of progression to dysplasia. We aimed to search the immunohistochemical expression of CDX2, COX2 and MUC2 in Barrett's esophagus to detect any early evidence of intestinal metaplasia or dysplasia.
Kaynak
Türk Patoloji Dergisi / Turkish Journal of PathologyCilt
28Sayı
3Bağlantı
http://www.turkjpath.org/text.php3?doi=10.5146/tjpath.2012.01132https://hdl.handle.net/11446/646